Ketamine Completed Phase 1 Trials for Psychotic-like Symptoms / Ketamine-Induced Brain Activity Changes Basic Science

IndicationsStatusPurposePhase
CompletedBasic Science1
clinicaltrials.gov IdentifierTitleDrugs
NCT01892189Effects of TAK-063 on Preventing Ketamine-Induced Brain Activity Changes as Well as Psychotic-Like Symptoms in Healthy Male Adults